by Ryan Watts | Mar 26, 2019 | Blog
In the event of the UK leaving the EU without a deal, a wholesale dealer may import Qualified Person certified medicines form the EEA if certain checks are made by the Responsible Person import (RPi) RP-i has an important role in ensuring that only bona fide quality... by Jackie Peck | Mar 20, 2019 | Blog
The role of the RPi is described in regulations 45AA & 45AB of the Human Medicines Regulations 2012 (as amended). The draft legislation is live but not yet approved by the Houses of Parliament…
by John Finey | Mar 18, 2019 | Blog
With everything going on at the moment it is easy to forget that there are things other than Brexit happening. An important one for the pharma supply chain is the scheduling of Pregabalin and Gabapentin as Class C, schedule 3 controlled drugs from 1st April 2019….
by Jackie Peck | Mar 18, 2019 | Blog
If a pharmacy allows the pharmacist to supply different strengths , quality or pharmaceutical form or indeed a different medicine to the prescription only medicine prescribed, using the newly agreed ” Serious Shortage Protocol ” who is liable if the... by Jackie Peck | Mar 18, 2019 | Blog
The Government is advising people that they must obtain their own travel insurance after Brexit. This is because the European Health Insurance Card the EHIC will disappear over night. This will also affect all the UK citizens who currently live abroad and take up... by Jackie Peck | Mar 18, 2019 | Blog
From the 1st of April 2019 pregabalin and gabapentin will be re-classified as class C controlled substances in the UK. The change has been prompted due to a sharp increase in deaths which toxicology has proved an association with the medicines. In addition the...